Latigo Biotherapeutics, Inc. (LTGO) has 2 open-market insider trades by 2 insiders since 2026. Over the last six months insiders net bought $5.0M. The most active filer is James B. Tananbaum, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James B. Tananbaum | Dir10% Owner | — | 1 | $2.5M | 2026-08-10 |
| Foresite Capital Management V, LLC | 10% Owner | — | 1 | $2.5M | 2026-08-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James B. Tananbaum | Director & 10% Owner | Buy | $2.5M | 2026-08-10 |
Companies that share insiders with LTGO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.